A case of readministration of nivolumab by treating with apremilast for psoriasiform eruption as irAE

A case of readministration of nivolumab by treating with apremilast for psoriasiform eruption as irAE

Bibliographic Details
Main Authors:	Naohisa Ichiki, Toshiaki Tanabe, Satoko Hisada, Miho Sugata, Yumi Ito, Tomonori Komatsu, Masanori Kodera
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-06-01
Series:	Journal of Cutaneous Immunology and Allergy
Online Access:	https://doi.org/10.1002/cia2.12157

Similar Items

Psoriasiform eruption on the face and extremities associated with nivolumab therapy
by: Amit Om, MD, et al.
Published: (2018-05-01)

Readministration of adenoviral gene delivery to dopamine neurons.
by: Gonzalez, S, et al.
Published: (2007)

Hyperacute Radiation Pneumonitis after Severe irAE
by: Yang Chou, et al.
Published: (2024-04-01)

Psoriasiform Drug Eruption Associated with Sodium Valproate
by: Gulen Gul Mert, et al.
Published: (2013-01-01)

Psoriasiform Eruption Clearance Following Psychiatric Treatment
by: Reza Bidaki, et al.
Published: (2019-01-01)

Cyclosporine for refractory Kawasaki disease with psoriasiform eruption
by: Mara Leyendecker, BS, et al.
Published: (2021-04-01)

Review of Immune-Related Adverse Events (irAEs) in Non-Small-Cell Lung Cancer (NSCLC)—Their Incidence, Management, Multiorgan irAEs, and Rechallenge
by: Raju Vaddepally, et al.
Published: (2022-03-01)

Editorial: Immune-related adverse Events (irAEs) of biopharmaceuticals
by: Alexander Batista-Duharte, et al.
Published: (2023-05-01)

4401 Incidence, management, and outcomes of immune-related adverse events (irAEs): an analysis of a multidisciplinary toxicity team for cancer immunotherapy related irAEs
by: Aanika Balaji, et al.
Published: (2020-06-01)

Readministration of Cancer Drugs in a Patient with Chemorefractory Metastatic Colorectal Cancer
by: Tetsuro Kawagoe, et al.
Published: (2020-01-01)

A case of psoriasiform drug eruption caused by temozolomide
by: Tokuko Oguro, et al.
Published: (2022-10-01)

An asthmatic case of psoriasiform eruption caused by administration of dupilumab
by: Takashi Matsuda, et al.
Published: (2020-07-01)

Apremilast
by: Nihal Kundakçı
Published: (2022-04-01)

A case of sialadenitis observed as an irAE of atezolizumab: A case report
by: Kosumi Kumagai, et al.
Published: (2024-01-01)

Co Treatment With Biologic Agents and Immunotherapy in the Setting of irAEs of Difficult Management
by: Virginia Robles-Alonso, et al.
Published: (2022-06-01)

B cell focused transient immune suppression protocol for efficient AAV readministration to the liver
by: Jyoti Rana, et al.
Published: (2024-03-01)

Psoriasiform rash following maculopapular eruption during the continued administration of pembrolizumab
by: Mayu Sato, et al.
Published: (2024-09-01)

Psoriasiform Drug Eruption Caused by Abatacept: Immunohistochemical Investigation of STAT Signaling
by: Kayo Tanita, et al.
Published: (2015-07-01)

A case of malignant melanoma with shrinking metastases after sequential severe irAEs
by: Aya Maekawa, et al.
Published: (2020-04-01)

Clinical benefit of readministration of gefitinib for initial gefitinib-responders with non-small cell lung cancer
by: Harada Masao, et al.
Published: (2007-03-01)

Psoriasiform Keratosis - Case report
by: Carla Andréa Avelar Pires, et al.
Published: (2014-04-01)

Histopathological spectrum of Psoriasiform dermatitis
by: PL Jayalakshmy, et al.
Published: (2016-09-01)

Lenvatinib-induced psoriasiform eruption and palmoplantar erythema in a patient with hepatocellular carcinoma
by: Rachel Sally, BA, et al.
Published: (2021-09-01)

Successful Readministration of AAV8 Following Administration of Nondepleting CD4 Antibody at the Time of Vector Administration
by: McIntosh, J, et al.
Published: (2006)

Psoriasiform Fixed-Drug Eruption to Ibuprofen: A Rare Variant of Fixed-Drug Eruption in a Child
by: Annie Raizada, et al.
Published: (2021-01-01)

A rare case of apixaban-induced psoriasiform drug eruption: A case report
by: Ghamdan Al-Aghbari, et al.
Published: (2024-11-01)

Histological analysis of psoriasiform eruption associated with myelin oligodendrocyte glycoprotein antibody-associated disease
by: Saori Itoi-Ochi, MD, PhD, et al.
Published: (2024-04-01)

Pityriasis Rosea Presenting as Psoriasiform Plaque
by: Abhijit Saha, et al.
Published: (2024-01-01)

Psoriasiform dermatoses: the diagnostic challenges revisited
by: Shruti Bhargava, et al.
Published: (2022-04-01)

Psoriasiform Skin Lesions and Dental Abnormalities
by: Huda Al Maqbali, et al.
Published: (2024-05-01)

Psoriasiform Lupus Vulgaris : An Unusual Presentation
by: Rathi Sanjay K
Published: (2000-01-01)

An unusual etiology for an acral psoriasiform dermatosis
by: Dimitra Koumaki, et al.
Published: (2020-01-01)

Molecular Mechanisms of Cutaneous Immune-Related Adverse Events (irAEs) Induced by Immune Checkpoint Inhibitors
by: Yi-Shan Teng, et al.
Published: (2023-07-01)

1245 Th17 and Type 2 CD8+ cytokine signatures predict irAEs in solid tumors
by: Evan J Lipson, et al.
Published: (2023-11-01)

Development of an eHealth Tool for Capturing and Analyzing the Immune-related Adverse Events (irAEs) in Cancer Treatment
by: Saeed Moradian, et al.
Published: (2023-06-01)

Current Diagnosis and Management of Immune Related Adverse Events (irAEs) Induced by Immune Checkpoint Inhibitor Therapy
by: Vivek Kumar, et al.
Published: (2017-02-01)

Apremilast Cocrystals with Phenolic Coformers
by: Yelizaveta Naumkina, et al.
Published: (2024-12-01)

Repigmentation of Tenacious Vitiligo on Apremilast
by: Sara B. Huff, et al.
Published: (2017-01-01)

Psychiatric risk profile of apremilast
by: Mustafa Ekici, et al.
Published: (2024-07-01)

Apremilast for lithium-associated psoriasis
by: Joohyung Youh, et al.
Published: (2022-01-01)